Liminal BioSciences Inc expected to post a loss of 34 cents a share - Earnings Preview

Liminal BioSciences

09/11/2021 03:03

* Liminal BioSciences Inc  LMNL.OQ   LMNL.O  is expected to show
a fall in quarterly revenue when it reports  results on November
10 (estimated). 
* The Belleville, Ontario-based company is expected to report  a
95.9% decrease in revenue to C$26 thousand from C$639 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Liminal BioSciences Inc
is for a loss of 34 cents per share. For the same quarter last
year, the company reported a loss of 98 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Liminal
BioSciences Inc is $4​, about 57.8% above​ its last closing
price of $1.69. ​​​
* Previous quarterly performance (using preferred earnings
measure in Canadian dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.53       -0.53      -1.07     Missed  -101.9
 Mar. 31 2021  -0.63       -0.63      -0.68     Missed  -7.9
 Dec. 31 2020  -0.73       -0.73      -1.45     Missed  -99.5​
 Sep. 30 2020  -1.01       -1.01      -0.98     Beat    3
 ​​                                                     
                                                        ​
 This summary was machine generated November 9 at 03:02 GMT.  All
figures in Canadian dollars unless otherwise stated